uni-leipzig-open-access/json/s00059-023-05174-6

{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,6,14]],"date-time":"2023-06-14T09:40:48Z","timestamp":1686735648705},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2023,4,25]],"date-time":"2023-04-25T00:00:00Z","timestamp":1682380800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,4,25]],"date-time":"2023-04-25T00:00:00Z","timestamp":1682380800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Herz"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1007\/s00059-023-05174-6","type":"journal-article","created":{"date-parts":[[2023,4,25]],"date-time":"2023-04-25T15:28:05Z","timestamp":1682436485000},"page":"218-222","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Das ver\u00e4nderte Spektrum kardiovaskul\u00e4rer Notf\u00e4lle w\u00e4hrend der COVID-19-Pandemie","The changing spectrum of cardiovascular emergencies during the COVID-19 pandemic"],"prefix":"10.1007","volume":"48","author":[{"given":"Holger","family":"Thiele","sequence":"first","affiliation":[]},{"given":"Uwe","family":"Zeymer","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2023,4,25]]},"reference":[{"key":"5174_CR1","doi-asserted-by":"publisher","first-page":"2372","DOI":"10.1016\/j.jacc.2020.03.021","volume":"75","author":"FGP Welt","year":"2020","unstructured":"Welt\u00a0FGP, Shah\u00a0PB, Aronow\u00a0HD et al (2020) Catheterization laboratory considerations during the Coronavirus (COVID-19) pandemic: from ACC\u2019s interventional council and SCAI. J Am Coll Cardiol 75:2372\u20132375","journal-title":"J. Am. Coll. Cardiol."},{"issue":"19","key":"5174_CR2","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1093\/eurheartj\/ehaa381","volume":"41","author":"A Chieffo","year":"2020","unstructured":"Chieffo\u00a0A, Stefanini\u00a0GG, Price\u00a0S et al (2020) EAPCI position statement on invasive management of acute coronary syndromes during the COVID-19 pandemic. Eur Heart\u00a0J 41(19):1839\u20131851","journal-title":"Eur Heart J"},{"issue":"14","key":"5174_CR3","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1093\/eurheartj\/ehaa575","volume":"42","author":"J-P Collet","year":"2020","unstructured":"Collet\u00a0J\u2011P, Thiele\u00a0H, Barbato\u00a0E et al (2020) 2020 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: the task force for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation of the European society of cardiology (ESC). Eur Heart\u00a0J 42(14):1289\u20131367","journal-title":"Eur Heart J"},{"issue":"23","key":"5174_CR4","doi-asserted-by":"publisher","first-page":"2950","DOI":"10.1016\/j.jacc.2020.04.031","volume":"75","author":"B Bikdeli","year":"2020","unstructured":"Bikdeli\u00a0B, Madhavan\u00a0MV, Jimenez\u00a0D et al (2020) COVID-19 and thrombotic or thromboembolic disease: Implications for prevention, antithrombotic therapy, and follow-up: JACC state-of-the-art review. J\u00a0Am Coll Cardiol 75(23):2950\u20132973","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"5174_CR5","doi-asserted-by":"publisher","first-page":"e007274","DOI":"10.1161\/CIRCHEARTFAILURE.120.007274","volume":"13","author":"C Andersson","year":"2020","unstructured":"Andersson\u00a0C, Gerds\u00a0T, Fosb\u00f8l\u00a0E et al (2020) Incidence of new-onset and worsening heart failure before and after the COVID-19 epidemic lockdown in Denmark. Circ Heart Fail 13(6):e7274","journal-title":"Circ Heart Fail"},{"issue":"3","key":"5174_CR6","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.jacc.2020.05.038","volume":"76","author":"AS Bhatt","year":"2020","unstructured":"Bhatt\u00a0AS, Moscone\u00a0A, McElrath\u00a0EE et al (2020) Fewer hospitalizations for acute cardiovascular conditions during the COVID-19 pandemic. J Am Coll Cardiol 76(3):280\u2013288","journal-title":"J. Am. Coll. Cardiol."},{"issue":"3","key":"5174_CR7","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1093\/ehjqcco\/qcaa049","volume":"6","author":"A Bollmann","year":"2020","unstructured":"Bollmann\u00a0A, Hohenstein\u00a0S, Meier-Hellmann\u00a0A et al (2020) Emergency hospital admissions and interventional treatments for heart failure and cardiac arrhythmias in Germany during the Covid-19 outbreak: insights from the German-wide Helios hospital network. Eur Heart J Qual Care Clin Outcomes 6(3):221\u2013222","journal-title":"Eur. Heart J. Qual. Care Clin. Outcomes"},{"issue":"19","key":"5174_CR8","doi-asserted-by":"publisher","first-page":"1852","DOI":"10.1093\/eurheartj\/ehaa314","volume":"41","author":"B Metzler","year":"2020","unstructured":"Metzler\u00a0B, Siostrzonek\u00a0P, Binder\u00a0RK, Bauer\u00a0A, Reinstadler\u00a0SJ (2020) Decline of acute coronary syndrome admissions in Austria since the outbreak of COVID-19: the pandemic response causes cardiac collateral damage. Eur Heart\u00a0J 41(19):1852\u20131853","journal-title":"Eur Heart J"},{"issue":"22","key":"5174_CR9","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.1093\/eurheartj\/ehaa409","volume":"41","author":"S De Rosa","year":"2020","unstructured":"De Rosa\u00a0S, Spaccarotella\u00a0C, Basso\u00a0C et al (2020) Reduction of hospitalizations for myocardial infarction in Italy in the COVID-19 era. Eur Heart\u00a0J 41(22):2083\u20132088","journal-title":"Eur Heart J"},{"issue":"22","key":"5174_CR10","doi-asserted-by":"publisher","first-page":"2871","DOI":"10.1016\/j.jacc.2020.04.011","volume":"75","author":"S Garcia","year":"2020","unstructured":"Garcia\u00a0S, Albaghdadi\u00a0MS, Meraj\u00a0PM et al (2020) Reduction in ST-segment elevation cardiac catheterization laboratory activations in the United States during COVID-19 pandemic. J Am Coll Cardiol 75(22):2871\u20132872","journal-title":"J. Am. Coll. Cardiol."},{"issue":"6","key":"5174_CR11","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1002\/ejhf.1925","volume":"22","author":"DI Bromage","year":"2020","unstructured":"Bromage\u00a0DI, Cannat\u00e0\u00a0A, Rind\u00a0IA et al (2020) The impact of COVID-19 on heart failure hospitalization and management: report from a\u00a0heart failure unit in London during the peak of the pandemic. Eur J Heart Fail 22(6):978\u2013984","journal-title":"Eur J Heart Fail"},{"issue":"6","key":"5174_CR12","doi-asserted-by":"publisher","first-page":"e008722","DOI":"10.1161\/CIRCEP.120.008722","volume":"13","author":"F Migliore","year":"2020","unstructured":"Migliore\u00a0F, Zorzi\u00a0A, Gregori\u00a0D et al (2020) Urgent pacemaker implantation rates in the Veneto region of Italy after the COVID-19 outbreak. Circ Arrhythm Electrophysiol 13(6):e8722","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"23","key":"5174_CR13","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1136\/heartjnl-2020-317650","volume":"106","author":"CS Kwok","year":"2020","unstructured":"Kwok\u00a0CS, Gale\u00a0CP, Kinnaird\u00a0T et al (2020) Impact of COVID-19 on percutaneous coronary intervention for ST-elevation myocardial infarction. Heart 106(23):1805\u20131811","journal-title":"Heart"},{"issue":"4","key":"5174_CR14","doi-asserted-by":"publisher","first-page":"e006631","DOI":"10.1161\/CIRCOUTCOMES.120.006631","volume":"13","author":"T C-CF","year":"2020","unstructured":"C\u2011CF T, Cheung\u00a0K\u2011S, Lam\u00a0S et al (2020) Impact of coronavirus disease 2019 (COVID-19) outbreak on ST-segment elevation myocardial infarction care in Hong Kong, China. Circ Cardiovasc Qual Outcomes 13(4):e6631","journal-title":"Circ. Cardiovasc. Qual. Outcomes"},{"issue":"7","key":"5174_CR15","doi-asserted-by":"publisher","first-page":"e009438","DOI":"10.1161\/CIRCINTERVENTIONS.120.009438","volume":"13","author":"SJ Wilson","year":"2020","unstructured":"Wilson\u00a0SJ, Connolly\u00a0MJ, Elghamry\u00a0Z et al (2020) Effect of the COVID-19 pandemic on ST-segment elevation myocardial infarction presentations and in-hospital outcomes. Circ Cardiovasc Interv 13(7):e9438","journal-title":"Circ Cardiovasc Interv"},{"issue":"12","key":"5174_CR16","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1007\/s00392-020-01705-x","volume":"109","author":"AK Gitt","year":"2020","unstructured":"Gitt\u00a0AK, Karcher\u00a0AK, Zahn\u00a0R, Zeymer\u00a0U (2020) Collateral damage of COVID-19-lockdown in Germany: decline of NSTE-ACS admissions. Clin Res Cardiol 109(12):1585\u20131587","journal-title":"Clin Res Cardiol"},{"issue":"12","key":"5174_CR17","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1007\/s00392-020-01703-z","volume":"109","author":"KH Scholz","year":"2020","unstructured":"Scholz\u00a0KH, Lengenfelder\u00a0B, Thilo\u00a0C et al (2020) Impact of COVID-19 outbreak on regional STEMI care in Germany. Clin Res Cardiol 109(12):1511\u20131521","journal-title":"Clin Res Cardiol"},{"issue":"12","key":"5174_CR18","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1007\/s00392-020-01688-9","volume":"109","author":"V Schwarz","year":"2020","unstructured":"Schwarz\u00a0V, Mahfoud\u00a0F, Lauder\u00a0L et al (2020) Decline of emergency admissions for cardiovascular and cerebrovascular events after the outbreak of COVID-19. Clin Res Cardiol 109(12):1500\u20131506","journal-title":"Clin Res Cardiol"},{"issue":"12","key":"5174_CR19","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1007\/s00392-020-01723-9","volume":"109","author":"M Seiffert","year":"2020","unstructured":"Seiffert\u00a0M, Brunner\u00a0FJ, Remmel\u00a0M et al (2020) Temporal trends in the presentation of cardiovascular and cerebrovascular emergencies during the COVID-19 pandemic in Germany: an analysis of health insurance claims. Clin Res Cardiol 109(12):1540\u20131548","journal-title":"Clin Res Cardiol"},{"key":"5174_CR20","doi-asserted-by":"publisher","author":"U Zeymer","year":"2022","unstructured":"Zeymer\u00a0U, Ahmadli\u00a0V, Schneider\u00a0S et al (2022) Effects of the COVID-19 pandemic on acute coronary syndromes in Germany during the first wave: the COVID-19 collateral damage study. Clin Res Cardiol. https:\/\/doi.org\/10.1007\/s00392-022-02082-3","journal-title":"Clin Res Cardiol","DOI":"10.1007\/s00392-022-02082-3"},{"issue":"33","key":"5174_CR21","doi-asserted-by":"publisher","first-page":"3164","DOI":"10.1093\/eurheartj\/ehac227","volume":"43","author":"R Nadarajah","year":"2022","unstructured":"Nadarajah\u00a0R, Wu\u00a0J, Hurdus\u00a0B et al (2022) The collateral damage of COVID-19 to cardiovascular services: a\u00a0meta-analysis. Eur Heart\u00a0J 43(33):3164\u20133178","journal-title":"Eur Heart J"},{"key":"5174_CR22","doi-asserted-by":"publisher","author":"G Tsigkas","year":"2021","unstructured":"Tsigkas\u00a0G, Koufou\u00a0E\u2011E, Katsanos\u00a0K et al (2021) Potential relationship between lifestyle changes and incidence of hospital admissions for acute coronary syndrome during the COVID-19 lockdown. Front Cardiovasc Med. https:\/\/doi.org\/10.3389\/fcvm.2021.604374","journal-title":"Front Cardiovasc Med","DOI":"10.3389\/fcvm.2021.604374"},{"issue":"11","key":"5174_CR23","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1093\/eurheartj\/ehab621","volume":"43","author":"I Lechner","year":"2021","unstructured":"Lechner\u00a0I, Reindl\u00a0M, Tiller\u00a0C et al (2021) Impact of COVID-19 pandemic restrictions on ST-elevation myocardial infarction: a\u00a0cardiac magnetic resonance imaging study. Eur Heart\u00a0J 43(11):1141\u20131153","journal-title":"Eur Heart J"},{"key":"5174_CR24","doi-asserted-by":"publisher","author":"U Zeymer","year":"2022","unstructured":"Zeymer\u00a0U, Ahmadli\u00a0V, Schneider\u00a0S et al (2022) Effects of the COVID-19 pandemic on acute coronary syndromes in Germany during the first wave\u2014the COVID-19 collateral damage study. Clin Res Cardiol. https:\/\/doi.org\/10.1007\/s00392-022-02082-3","journal-title":"Clin Res Cardiol","DOI":"10.1007\/s00392-022-02082-3"},{"issue":"6","key":"5174_CR25","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1136\/heartjnl-2020-318360","volume":"107","author":"M Rattka","year":"2021","unstructured":"Rattka\u00a0M, Dreyhaupt\u00a0J, Winsauer\u00a0C et al (2021) Effect of the COVID-19 pandemic on mortality of patients with STEMI: a\u00a0systematic review and meta-analysis. Heart 107(6):482\u2013487","journal-title":"Heart"},{"issue":"32","key":"5174_CR26","doi-asserted-by":"publisher","first-page":"3045","DOI":"10.1093\/eurheartj\/ehaa508","volume":"41","author":"E Baldi","year":"2020","unstructured":"Baldi\u00a0E, Sechi\u00a0GM, Mare\u00a0C et al (2020) COVID-19 kills at home: the close relationship between the epidemic and the increase of out-of-hospital cardiac arrests. Eur Heart\u00a0J 41(32):3045\u20133054","journal-title":"Eur Heart J"},{"key":"5174_CR27","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.resuscitation.2020.12.020","volume":"159","author":"E Baldi","year":"2021","unstructured":"Baldi\u00a0E, Primi\u00a0R, Gentile\u00a0FR et al (2021) Out-of-hospital cardiac arrest incidence in the different phases of COVID-19 outbreak. Resuscitation 159:115\u2013116","journal-title":"Resuscitation"},{"issue":"1","key":"5174_CR28","doi-asserted-by":"publisher","first-page":"e2032331","DOI":"10.1001\/jamanetworkopen.2020.32331","volume":"4","author":"AV Nickles","year":"2021","unstructured":"Nickles\u00a0AV, Oostema\u00a0A, Allen\u00a0J et al (2021) Comparison of out-of-hospital cardiac arrests and fatalities in the Metro Detroit Area during the COVID-19 pandemic with previous-year events. JAMA Netw Open 4(1):e2032331","journal-title":"JAMA Netw Open"},{"issue":"22","key":"5174_CR29","doi-asserted-by":"publisher","first-page":"e018379","DOI":"10.1161\/JAHA.120.018379","volume":"9","author":"M Rashid Hons","year":"2020","unstructured":"Rashid Hons\u00a0M, Gale Hons\u00a0CP, Curzen Hons\u00a0N et al (2020) Impact of Coronavirus disease 2019 pandemic on the incidence and management of out-of-hospital cardiac arrest in patients presenting with acute myocardial infarction in England. J\u00a0Am Heart Assoc 9(22):e18379","journal-title":"J Am Heart Assoc"},{"key":"5174_CR30","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1007\/s00392-020-01780-0","volume":"110","author":"HM Nef","year":"2021","unstructured":"Nef\u00a0HM, Els\u00e4sser\u00a0A, M\u00f6llmann\u00a0H et al (2021) Impact of the COVID-19 pandemic on cardiovascular mortality and catherization activity during the lockdown in central Germany: an observational study. Clin Res Cardiol 110:292\u2013301","journal-title":"Clin Res Cardiol"},{"issue":"20","key":"5174_CR31","doi-asserted-by":"publisher","first-page":"2321","DOI":"10.1016\/j.jacc.2020.09.546","volume":"76","author":"A Barrios","year":"2020","unstructured":"Barrios A, Becerra-Mu\u00f1oz V, Santucci A (2020) Impact of COVID-19 pandemic on mechanical reperfusion for patients with STEMI. J Am Coll Cardiol 76(20):2321\u20132330. https:\/\/doi.org\/10.1016\/j.jacc.2020.09.546","journal-title":"J Am Coll Cardiol"},{"issue":"100055","key":"5174_CR32","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/jlanepe.2021.10005534","volume":"3","author":"G Campo","year":"2021","unstructured":"Campo G, Fortuna D, Berti E et al (2021) In- and out-of-hospital mortality for myocardial infarction during the first wave of the COVID-19 pandemic in Emilia-Romagna, Italy: a populationbased observational study. Lancet Reg Health Eur 3:100055. https:\/\/doi.org\/10.1016\/jlanepe.2021.10005534","journal-title":"Lancet"},{"issue":"1","key":"5174_CR33","doi-asserted-by":"publisher","first-page":"3755","DOI":"10.1038\/s41467-021-23935-x","volume":"12","author":"B Davies","year":"2021","unstructured":"Davies B, Parkes BL, Bennett J et al (2021) Community factorsand excess mortality in first wave of the COVID-19 pandemicin England. Nat Commun 12(1):3755. https:\/\/doi.org\/10.1038\/s41467-021-23935-x","journal-title":"pandemicin England. Nat Commun"}],"container-title":["Herz"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00059-023-05174-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00059-023-05174-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00059-023-05174-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,14]],"date-time":"2023-06-14T09:03:07Z","timestamp":1686733387000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00059-023-05174-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,25]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["5174"],"URL":"http:\/\/dx.doi.org\/10.1007\/s00059-023-05174-6","relation":{},"ISSN":["0340-9937","1615-6692"],"issn-type":[{"value":"0340-9937","type":"print"},{"value":"1615-6692","type":"electronic"}],"subject":["Cardiology and Cardiovascular Medicine"],"published":{"date-parts":[[2023,4,25]]},"assertion":[{"value":"2 March 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"H.\u00a0Thiele declares that he has no competing interests. U.\u00a0Zeymer declares grants and personal fees from Astra Zeneca, grants and personal fees from Bayer, grants and personal fees from BMS, grants and personal fees from Daiichi Sankyo, personal fees from Boehringer Ingelheim, personal fees from Medicines Company, personal fees from Sanofi, personal fees from Ferrer, grants and personal fees from Novartis, outside the submitted work.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"For this article no studies with human participants or animals were performed by any of the authors. All studies mentioned were in accordance with the ethical standards indicated in each case.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}